儿童癌症长期幸存者心电图异常的患病率与临床应用价值
该横断面研究纳入荷兰儿童癌症幸存者研究第二部分的1381名幸存者(随访≥5年)与272名同胞,比较明尼苏达编码定义的心电图异常患病率,并在880名接受蒽环类、米托蒽醌或心脏放疗的幸存者中构建预测左心室射血分数(LVEF)异常的模型。结果显示,幸存者重大心电图异常占16%,同胞占14%;将部分心电图变量纳入基线模型可提升对性别特异性异常LVEF及LVEF<45%的预测能力,其中预测LVEF<45%的模型可用于排除(敏感度93%、特异度56%、阴性预测值99.6%)。
要点
- 幸存者重大心电图异常占16%,同胞占14%,心电图异常随LVEF下降而增多。
- 将心电图数据加入基线模型可提升对异常LVEF的预测(c统计量0.66对0.71等)。
- 含5个心电图变量的模型可用于排除LVEF<45%(敏感度93%、阴性预测值99.6%)。
核心结论
- 含心电图数据的临床预测模型(左束支传导阻滞、左心房扩大、左心轴、Cornell左心室肥厚标准及心率)可能有助于排除LVEF<45%。
研究设计与样本
- 横断面研究,纳入荷兰儿童癌症幸存者研究第二部分的1381名幸存者(随访≥5年)及272名同胞,均接受长期随访心电图与超声心动图检查。
- 在880名接受蒽环类、米托蒽醌或心脏放疗的幸存者中,用LASSO逻辑回归识别与三类异常LVEF相关的心电图异常。
主要发现
- 16%的幸存者(52%女性,平均年龄34.7岁)与14%的同胞存在重大心电图异常。
- 心电图异常随LVEF降低而增多。
- 将所选心电图数据纳入基线模型显著改善对性别特异性异常LVEF(c统计量0.66对0.71)、LVEF<50%(0.66对0.76)及LVEF<45%(0.80对0.86)的预测。
- 前两个模型无幸存者达到预设概率阈值;第三个模型用5个心电图变量预测LVEF<45%,可用于排除(敏感度93%、特异度56%、阴性预测值99.6%)。
- 校准与内部验证表现良好。
关键数值与推荐
- 重大心电图异常:幸存者16%,同胞14%。
- 性别特异性异常LVEF定义:男性<52%、女性<54%;另设LVEF<50%与LVEF<45%两类。
- 预测LVEF<45%的模型含5个心电图变量:左束支传导阻滞、左心房扩大、左心轴、Cornell左心室肥厚标准、心率。
- 排除LVEF<45%时敏感度93%、特异度56%、阴性预测值99.6%,假设无收缩功能障碍的阈值概率<1%。
临床怎么用
- 对接受蒽环类、米托蒽醌或心脏放疗的儿童癌症长期幸存者,可考虑将心电图变量纳入临床模型,用于排除LVEF<45%。
- 该模型不适用于排除性别特异性异常LVEF或LVEF<50%(前两个模型无幸存者达到预设概率阈值)。
局限性
- 原文摘要未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We assessed the prevalence and diagnostic value of ECG abnormalities for cardiomyopathy surveillance in childhood cancer survivors. METHODS: In this cross-sectional study, 1381 survivors (≥5 years) from the Dutch Childhood Cancer Survivor Study part 2 and 272 siblings underwent a long-term follow-up ECG and echocardiography. We compared ECG abnormality prevalences using the Minnesota Code between survivors and siblings, and within biplane left ventricular ejection fraction (LVEF) categories. Among 880 survivors who received anthracycline, mitoxantrone or heart radiotherapy, logistic regression models using least absolute shrinkage and selection operator identified ECG abnormalities associated with three abnormal LVEF categories (<52% in male/<54% in female, <50% and <45%). We assessed the overall contribution of these ECG abnormalities to clinical regression models predicting abnormal LVEF, assuming an absence of systolic dysfunction with a <1% threshold probability. RESULTS: 16% of survivors (52% female, mean age 34.7 years) and 14% of siblings had major ECG abnormalities. ECG abnormalities increased with decreasing LVEF. Integrating selected ECG data into the baseline model significantly improved prediction of sex-specific abnormal LVEF (c-statistic 0.66 vs 0.71), LVEF <50% (0.66 vs 0.76) and LVEF <45% (0.80 vs 0.86). While no survivor met the preset probability threshold in the first two models, the third model used five ECG variables to predict LVEF <45% and was applicable for ruling out (sensitivity 93%, specificity 56%, negative predictive value 99.6%). Calibration and internal validation tests performed well. CONCLUSION: A clinical prediction model with ECG data (left bundle branch block, left atrial enlargement, left heart axis, Cornell's criteria for left ventricular hypertrophy and heart rate) may aid in ruling out LVEF <45%.
引用
- de Baat EC, Merkx R, Leerink JM, et al. Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors. Heart. 2024. PMID: 38503487. doi:10.1136/heartjnl-2023-323474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。